Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, if his Department will make an assessment of the potential merits of introducing specialised commissioning for therapeutic plasma exchange for neurological conditions.

Any decision to commission specialised interventions such as therapeutic plasma exchange (PLEX) for neurological conditions is a matter for NHS England. All decisions on treatment are made by clinical experts, informed by a patient's individual clinical needs. Wherever clinically appropriate, use of alternative therapies to immunoglobulin treatment for patients with neurological conditions, including PLEX, is stated in the current commissioning guidance which is available at the following link:

https://www.england.nhs.uk/wp-content/uploads/2019/03/PSS9-Immunoglobulin-Commissioning-Guidance-CQUIN-1920.pdf